Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04109755
Title Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer (PEMREC)
Acronym PEMREC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Geneva
Indications
Therapies
Age Groups: senior | adult
Covered Countries CHE

Facility Status City State Zip Country Details
Hôpitaux Universitaires de Genève RECRUITING Geneva 1205 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field